Novavax, Inc. a clinical-stage vaccine company, announced that the company will be presenting at the American Society for Microbiology (ASM) sponsored, ICAAC. The Conference will take place September 11-15, 2010 at the Boston Convention and Exhibition Center, Boston, MA. Drs. Steven Pincus and Ramadevi Raghunandan will be presenting multiple abstracts including, “Functional Neuraminidase Plays a Key Role in Enhancing Immune Response and Protection against Influenza Virus,” and “Immunization of Healthy Adults with H5N1 Influenza Virus-Like Particle (VLP) Vaccine Induces Cell Mediated and Humoral Immunity Including Functional Antibodies against Neuraminidase,” during the poster sessions on Sunday, September 12, 2010, and Tuesday, September 14, 2010.
These two Novavax presentations, mentioned above, have been selected by the ASM Communications Committee and the ICAAC Program Committee to be highlighted in the conference’s press room.
“We are all excited that ASM is recognizing our work as novel and newsworthy,” said Dr. Raghunandan.
Source: Novavax, Inc.